Business Wire (Tue, 8:00AM)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
145 people get SRDX articles and Market Currents by email alert.
Get email alerts on SRDX »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Business Wire (May 7, 2013)
-
Business Wire (Apr 30, 2013)
-
Business Wire (Feb 11, 2013)
-
Business Wire (Feb 6, 2013)
-
Business Wire (Jan 30, 2013)
-
Business Wire (Jan 23, 2013)
-
-
Business Wire (Dec 21, 2012)
-
SurModics' CEO Discusses F4Q12 Results - Earnings Call TranscriptTue, Nov 6, 2012
-
Business Wire (Nov 6, 2012)
-
Business Wire (Oct 30, 2012)
-
5 Cash-Loaded Small Cap Stocks With Low To No DebtZetaKap • Fri, Oct 5, 2012 -
Business Wire (Sep 11, 2012)
-
Business Wire (Sep 7, 2012)
-
Business Wire (Sep 6, 2012)
-
7 Liquid Small-Cap Healthcare Stocks Rated Buy Or Better By AnalystsZetaKap • Tue, Aug 28, 2012
To learn more about Seeking Alpha Pro, click here.
-
Earnings Scorecard: SurModicsZacks Investment Research • Thu, May 5, 2011 -
Surmodics: Convergence of Devices and DrugsAlan Brochstein • Tue, Oct 30, 2007 -
SurModics Acquires BioFX Laboratories For $22.7 MillionSara Calabro • Tue, Aug 14, 2007
-
-
5 Cash-Loaded Small Cap Stocks With Low To No DebtZetaKap • Fri, Oct 5, 2012
-
7 Liquid Small-Cap Healthcare Stocks Rated Buy Or Better By AnalystsZetaKap • Tue, Aug 28, 2012
-
8 Highly Liquid Healthcare Stocks Undervalued By EPS TrendsKapitall • Thu, Aug 23, 2012
-
-
-
-
-
-
-
-
-
-
-
-
-
-
7 Healthcare Stocks for a Sick MarketAlan Brochstein • Sun, Jan 6, 2008
-
Three Stocks for a Tough MarketAlan Brochstein • Thu, Sep 6, 2007
-
SurModics' CEO Discusses F4Q12 Results - Earnings Call TranscriptTue, Nov 6, 2012
-
SurModics' CEO Discusses F3Q12 Results - Earnings Call TranscriptWed, Aug 1, 2012
-
SurModics' CEO Discusses F2Q2012 Results - Earnings Call TranscriptTue, May 8, 2012
-
SurModics' CEO Hosts Annual Shareholder Meeting (Transcript)Sun, Feb 19, 2012
-
SurModics' CEO Discusses F4Q 2011 Results - Earnings Call TranscriptFri, Nov 4, 2011
-
SurModics CEO Discusses F3Q2011 Results - Earnings Call TranscriptWed, Aug 3, 2011
-
SurModics' CEO Discusses Q2 2011 Results - Earnings Call TranscriptWed, Apr 27, 2011
-
SurModics CEO Discusses F4Q2010 Results - Earnings Call TranscriptWed, Nov 10, 2010
-
SurModics, Inc., F3Q10 (Qtr End 06/30/2010) Earnings Call TranscriptWed, Jul 28, 2010
-
SurModics, Inc. F2Q10 (Qtr End 03/31/10) Earnings Call TranscriptWed, Apr 28, 2010
-
SurModics, Inc. F1Q10 (Qtr End 12/31/09) Earnings Call TranscriptThu, Jan 28, 2010
-
SurModics, Inc.Q4 2009 Earnings Call TranscriptWed, Nov 4, 2009
-
SurModics Q2 2009 Earnings TranscriptThu, Jul 30, 2009
-
SurModics Inc. F2Q09 (Qtr End 03/31/09) Earnings Call TranscriptThu, Apr 30, 2009
-
SurModics, Inc. F1Q09 (Qtr End 12/31/08) Earnings Call TranscriptWed, Jan 28, 2009
-
Business Wire (Tue, 8:00AM)
-
Business Wire (May 7, 2013)
-
Business Wire (Apr 30, 2013)
-
Business Wire (Feb 11, 2013)
-
Business Wire (Feb 6, 2013)
-
Business Wire (Jan 30, 2013)
-
Business Wire (Jan 23, 2013)
-
Business Wire (Dec 21, 2012)
-
Business Wire (Nov 6, 2012)
-
Business Wire (Oct 30, 2012)
-
at MarketWatch.com (Sep 13, 2012)
-
Business Wire (Sep 11, 2012)
-
Business Wire (Sep 7, 2012)
-
Business Wire (Sep 6, 2012)
-
Business Wire (Aug 27, 2012)
-
at Fox Business (Aug 15, 2012)
-
at Fox Business (Aug 15, 2012)
-
at Fox Business (Aug 15, 2012)
-
Business Wire (Aug 6, 2012)
-
at MarketWatch.com (Aug 2, 2012)
SRDX vs. ETF Alternatives
Company Description
SurModics, Inc. is a leading provider of drug delivery and surface modification technologies to the healthcare industry. Our mission is to exceed our customers’ expectations and enhance the well-being of patients by providing the world’s foremost, innovative drug delivery and surface... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Tuesday, May 7, 5:18 PM SurModics (SRDX): FQ2 EPS of $0.20 misses by $0.01. Revenue of $13.7M (+12% Y/Y) misses by $0.22M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Wednesday, January 30, 4:41 PM SurModics (SRDX): FQ1 EPS of $0.22 beats by $0.04. Revenue of $13.9M (+16% Y/Y). (PR) Comment! [Earnings, Breaking News, Healthcare]
- Tuesday, November 6, 2012, 4:51 PM SurModics (SRDX): FQ4 EPS of $0.19 beats by $0.02. Revenue of $13.8M (-0.7% Y/Y) in-line. (PR) Comment! [Earnings, Healthcare]
- Wednesday, August 1, 2012, 7:05 PM SurModics (SRDX): FQ3 EPS of $0.17 beats by $0.03. Revenue of $14M (+7.4% Y/Y) beats by $1.6M. (PR) Comment! [Earnings, Healthcare]
- Tuesday, May 8, 2012, 5:30 PM SurModics (SRDX): Q1 EPS of $0.14 misses by $0.01. Revenue of $12.2M (-8.4% Y/Y). (PR) Comment! [Earnings, Healthcare]
- Friday, February 3, 2012, 8:41 AM SurModics (SRDX) says it may need to restate financial statements for Q4 and full-year 2011, citing accounting matters arising from the sale of pharmaceutical assets last November. Any potential adjustments would be "non-cash in nature," and not expecting to affect FQ1 2012 results. Preliminary FQ1 2012 results are in-line with expectations. Comment! [Healthcare]
- Thursday, August 4, 2011, 11:10 AM SurModics (SRDX +21%) shares soar after FQ3 results beat estimates late yesterday. The company's focus on its core business and managing execution costs boosted margins, while top-line sales were helped by five new license agreements in its Medical Device business. Comment! [Healthcare, On the Move]
- Wednesday, August 3, 2011, 4:13 PM SurModics (SRDX): FQ3 EPS of $0.13 beats by $0.09. Revenue of $17.9M (-3% Y/Y) beats by $1.7M. FY11 GAAP EPS at $0.03 to $0.13, compared to previous range of ($0.21)-($0.08). Shares -4.1% AH. (PR) Comment! [Earnings]
- Thursday, April 28, 2011, 12:58 PM Small medical-products maker SurModics (SRDX +17.3%) soaring today after reporting its second-quarter earnings swung from a year-ago loss of $0.02/share to a $0.14/share profit. That's now given it one of the higher forward P/Es in healthcare. (earnings call transcript) Comment! [On the Move, Healthcare, Earnings]
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.